MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review.?Sign up here?to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
SpaceX tender offer is said to value company at $140bn.
You can access today’s complete newsletter?here.
Scroll down for more…
诺维信 , a Danish food ingredients and enzyme maker, agreed to acquire Chr. Hansen , a bioscience company, for $12.3bn.
"The combination of two strategically complementary companies with a shared purpose and advanced capabilities will show the world the true power of biosolutions. Today's announcement is fully aligned with Novozymes' strategy and is another step towards unlocking additional growth opportunities. Novozymes and Chr. Hansen share the strong conviction that our combined scale, know-how, commercial strengths, and innovation excellence will drive value for our shareholders, customers, and society at large by providing the sustainable solutions the world so urgently needs," Ester Baiget, Novozymes President and CEO.
Chr. Hansen is advised by 高盛 , 贝克?麦坚时 , Gorrissen Federspiel and IMPACT Partners . Novozymes is advised by Danske Bank , Gordon Dyal & Co. Advisory Group LP , Nordea , Oxera Consulting LLP , Davis Polk & Wardwell LLP (led by? Connie Milonakis ?and? Will Pearce ), 年利达 , Plesner , FGS Global and Point Communications .
Takeda, a pharmaceutical company, agreed to acquire Nimbus Lakshmi, a wholly-owned subsidiary of Nimbus Therapeutics, a developer of small molecule compounds, for $6bn.
“Nimbus’ allosteric TYK2 inhibitor has the potential to be a best-in-class medicine in multiple disease areas, and we are confident that Takeda’s commitment and capabilities will enable NDI-034858 to reach its full value to patients. The proposed acquisition highlights Nimbus’ ability to discover and develop high-value investigational medicines leveraging our computational structure-based drug design and development engine. We will continue to advance other exciting target programs in our R&D pipeline — including our selective HPK1 inhibitor, currently in a Phase 1/2 study in patients with solid tumors — as we have done since our founding in 2009," Jeb Keiper, Nimbus CEO.
Takeda is advised by Evercore and Cleary Gottlieb Steen & Hamilton LLP . Nimbus is advised by J.P. 摩根 , Goodwin and Ten Bridge Communications .
Infinite Reality, a developer of metaverse innovation and entertainment platform, agreed to go public via a SPAC merger with Newbury Street Acquisition in a $1.85bn deal.
"Our team was blown away by the opportunity Infinite Reality has to truly revolutionize how people experience the internet in the future. Infinite Reality has the expertise, innovation, and scale to be a trailblazer helping brands connect directly with their audiences and customize their Metaverse experiences. Online commerce and entertainment will never be the same again. The creative talent and experience of this team sets iR apart, and all of us at Newbury are excited to be their long-term partner," Tom Bushey, Newbury CEO.
Infinite Reality is advised by BCLP , Fried Frank and Hill & Knowlton . Newbury is advised by Akerman LLP .
Veris Residential , a real estate investment trust, is releasing a letter it sent to Kushner Companies, an American real estate developer, in the spirit of transparency and to ensure that all Veris Residential shareholders have equal access to important information regarding the company.
In its letter, the Board details its unanimous rejection of each of Kushner Companies' latest unsolicited proposals to acquire Veris Residential and a go-forward process to facilitate constructive dialogue between Veris Residential and Kushner Companies. The Board also reiterates its willingness to evaluate any proposals from interested buyers that will maximize the value of Veris Residential's shares to the benefit of all Veris Residential shareholders.?
Veris Residential is advised by Gasthalter & Co. LP (led by? Amanda Shpiner ). Kushner Companies is advised by Okapi Partners (led by? Pat McHugh ?and? Bruce H. Goldfarb ).
SpaceX tender offer is said to value company at $140bn.
Elon Musk’s SpaceX is offering to sell insider shares at a price that would raise the closely held company’s valuation to about $140bn,?Bloomberg?reported.
Space Exploration Technologies is offering the shares for $77 apiece. The $140bn figure compares with a $127bn valuation in July.
Interested to find more??Sign up here?to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter?here.